MAPT and Alzheimer disease: Except for MS, in which Tregs are impaired [187], neurodegenerative diseases, such as AD and PD, are reported to have increased Tregs with higher activation in the peripheral blood [72], that likely suppress T effectors of pathological proteins such as Aβ and tau proteins in AD.